No abstract available
MeSH terms
-
Adult
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / therapeutic use
-
Bevacizumab
-
Combined Modality Therapy
-
Drug Resistance, Neoplasm
-
ErbB Receptors / antagonists & inhibitors
-
ErbB Receptors / metabolism
-
Humans
-
Podophyllotoxin / therapeutic use
-
Receptor, IGF Type 1 / antagonists & inhibitors
-
Sarcoma / metabolism
-
Sarcoma / therapy*
-
Soft Tissue Neoplasms / metabolism
-
Soft Tissue Neoplasms / therapy*
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Bevacizumab
-
ErbB Receptors
-
Receptor, IGF Type 1
-
Podophyllotoxin